Jonathan Matz

3.1k total citations · 1 hit paper
18 papers, 1.6k citations indexed

About

Jonathan Matz is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Jonathan Matz has authored 18 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Physiology, 8 papers in Pulmonary and Respiratory Medicine and 4 papers in Immunology and Allergy. Recurrent topics in Jonathan Matz's work include Asthma and respiratory diseases (13 papers), Respiratory and Cough-Related Research (8 papers) and Allergic Rhinitis and Sensitization (4 papers). Jonathan Matz is often cited by papers focused on Asthma and respiratory diseases (13 papers), Respiratory and Cough-Related Research (8 papers) and Allergic Rhinitis and Sensitization (4 papers). Jonathan Matz collaborates with scholars based in United States, Canada and Japan. Jonathan Matz's co-authors include Robert G. Townley, M. Solèr, H. Fox, J S O′Brien, J. Thirlwell, Giovanni Della Cioppa, Niroo Gupta, Roland Buhl, Barbara Knorr and Beth C. Seidenberg and has published in prestigious journals such as JAMA, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.

In The Last Decade

Jonathan Matz

17 papers receiving 1.5k citations

Hit Papers

The anti-IgE antibody omalizumab reduces exacerbations an... 2001 2026 2009 2017 2001 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan Matz United States 11 1.4k 1.1k 617 173 130 18 1.6k
Philippe Godard France 9 739 0.5× 697 0.6× 149 0.2× 70 0.4× 52 0.4× 12 909
Y Saraçlar Türkiye 16 463 0.3× 325 0.3× 247 0.4× 79 0.5× 23 0.2× 37 760
Christina Keen Sweden 13 965 0.7× 923 0.8× 126 0.2× 212 1.2× 58 0.4× 32 1.3k
Semanur Kuyucu Türkiye 17 414 0.3× 251 0.2× 349 0.6× 77 0.4× 142 1.1× 56 944
Gülfem Çelík Türkiye 20 578 0.4× 341 0.3× 361 0.6× 83 0.5× 51 0.4× 64 1.2k
Adriano Vaghi Italy 19 682 0.5× 652 0.6× 99 0.2× 54 0.3× 24 0.2× 51 1.1k
İpek Türktaş Türkiye 14 323 0.2× 236 0.2× 290 0.5× 41 0.2× 25 0.2× 60 705
Peter Cvietusa United States 8 408 0.3× 156 0.1× 132 0.2× 207 1.2× 28 0.2× 18 634
Victor E. Ortega United States 14 447 0.3× 367 0.3× 48 0.1× 104 0.6× 59 0.5× 49 820
Andrea M. Coverstone United States 11 566 0.4× 386 0.4× 57 0.1× 242 1.4× 16 0.1× 15 740

Countries citing papers authored by Jonathan Matz

Since Specialization
Citations

This map shows the geographic impact of Jonathan Matz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Matz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Matz more than expected).

Fields of papers citing papers by Jonathan Matz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Matz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Matz. The network helps show where Jonathan Matz may publish in the future.

Co-authorship network of co-authors of Jonathan Matz

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Matz. A scholar is included among the top collaborators of Jonathan Matz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Matz. Jonathan Matz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Sapkota, Amir, Ghassem Asrar, Yuyu Zhou, et al.. (2020). Association Between Changes in Timing of Spring Onset and Asthma Hospitalization in Maryland. JAMA Network Open. 3(7). e207551–e207551. 26 indexed citations
2.
Ford, Linda B., Jonathan Matz, Todd C. Hankinson, Barbara A. Prillaman, & George Georges. (2015). A comparison of fluticasone propionate nasal spray and cetirizine in ragweed fall seasonal allergic rhinitis. Allergy and Asthma Proceedings. 36(4). 313–319. 7 indexed citations
4.
Pearlman, David S., Paul Y. Qaqundah, Jonathan Matz, et al.. (2009). Fluticasone propionate/salmeterol and exercise‐induced asthma in children with persistent asthma. Pediatric Pulmonology. 44(5). 429–435. 19 indexed citations
5.
Bailey, William C., Mario Castro, Jonathan Matz, et al.. (2008). Asthma exacerbations in African Americans treated for 1 year with combination fluticasone propionate and salmeterol or fluticasone propionate alone. Current Medical Research and Opinion. 24(6). 1669–1682. 33 indexed citations
6.
Matz, Jonathan, et al.. (2002). An unusual case of Campylobacter jejuni pericarditis in a patient with X-linked agammaglobulinemia. Annals of Allergy Asthma & Immunology. 89(4). 362–367. 13 indexed citations
7.
Buhl, Roland, M. Solèr, Jonathan Matz, et al.. (2002). Omalizumab provides long-term control in patients with moderate-to-severe allergic asthma. European Respiratory Journal. 20(1). 73–78. 162 indexed citations
8.
Matz, Jonathan, Amanda Emmett, Kathleen Rickard, & Christopher Kalberg. (2001). Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: An analysis of asthma exacerbations. Journal of Allergy and Clinical Immunology. 107(5). 783–789. 95 indexed citations
9.
Williams, Betsy, Gertrude Noonan, T.F. Reiss, et al.. (2001). Long‐term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and older. Clinical & Experimental Allergy. 31(6). 845–854. 68 indexed citations
10.
Solèr, M., Jonathan Matz, Robert G. Townley, et al.. (2001). The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics. European Respiratory Journal. 18(2). 254–261. 647 indexed citations breakdown →
11.
Matz, Jonathan. (2000). 494 The combination of salmeterol and low-dose fluticasone versus higher-dose fluticasone: An analysis of asthma exacerbations. Journal of Allergy and Clinical Immunology. 105(1). S162–S162. 6 indexed citations
12.
Knorr, Barbara, Jonathan Matz, Jonathan A. Bernstein, et al.. (1999). Montelukast for Chronic Asthma in 6- to 14-Year-Old Children: A Randomized, Double-Blind Trial. Survey of Anesthesiology. 43(1). 31–31. 36 indexed citations
13.
Matz, Jonathan, et al.. (1998). Greater improvement in asthma control with fluticasone propionate than with either zafirlukast or placebo. CHEST Journal. 114. 2 indexed citations
14.
Knorr, Barbara, Jonathan Matz, Jonathan A. Bernstein, et al.. (1998). Montelukast for Chronic Asthma in 6- to 14-Year-Old Children. JAMA. 279(15). 1181–1181. 399 indexed citations
15.
Matz, Jonathan, Larry Borish, John M. Routes, & Lanny J. Rosenwasser. (1994). Oral Desensitization To Rifampin And Ethambutol In Mycobacterial Disease. American Journal of Respiratory and Critical Care Medicine. 149(3). 815–817. 50 indexed citations
16.
Matz, Jonathan, John Williams, Lanny J. Rosenwasser, & Larry Borish. (1994). Granulocyte-macrophage colony-stimulating factor stimulates macrophages to respond to IgE via the low affinity IgE receptor (CD23). Journal of Allergy and Clinical Immunology. 93(3). 650–657. 10 indexed citations
17.
Matz, Jonathan, John M. Routes, & Larry Borish. (1992). Diffuse pulmonary infiltrates in hypogammaglobulinemia.. PubMed. 69(6). 485–90. 3 indexed citations
18.
Heigh, Russell I., Jonathan Matz, Ingram M. Roberts, William M. Steinberg, & James P. Henry. (1990). Atypical Eating Disorder Masquerading as Recurrent Acute Pancreatitis. Journal of Clinical Gastroenterology. 12(1). 78–80. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026